Tag Archives: develop

ATAI Life Sciences acquires majority stake in Perception Neuroscience to develop arketamine therapy for neuropsychiatric diseases

Munich and New York, 03 January 2019 – ATAI Life Sciences AG has acquired a majority stake in New York based Perception Neuroscience, a biopharmaceutical company focused on developing innovative therapies in neuropsychiatry. Perception was founded by Jonathan Sporn, MD, and Jay Kranzler, MD, PhD, both of whom have held multiple senior R&D leadership roles… Read More »

Nicox teams up with Chinese firm to develop and sell glaucoma drug

PARIS (Reuters) – French ophthalmology company Nicox and Chinese firm Ocumension Therapeutics said on Monday they had signed an exclusive license agreement to develop and sell a yet-to-be approved Nicox drug to treat glaucoma in China. Glaucoma, which is damage to the optic nerve, is the second leading cause of blindness globally and is likely… Read More »

MRI brain scans better ID people likely to develop Alzheimer’s

Common clinical tests are no match for MRI brain exams when it comes to predicting which patients will develop Alzheimer’s disease. That’s among the findings of a study that will be presented at the annual meeting of the Radiological Society of North America, running from November 25 to 30 in Chicago. According to researchers, common… Read More »